All articles tagged with #urolithin a
A metabolite called urolithin A, produced by gut bacteria from pomegranate polyphenols, reduces oxidative stress and inflammation and stabilizes arterial plaques, lowering plaque size in a mouse model without changing cholesterol levels, pointing to a microbiome-based approach to cardiovascular disease; human studies are needed since individual gut microbiomes vary in producing urolithin A.
A study from the University of Copenhagen reveals that urolithin A, a compound found in pomegranates, strawberries, and walnuts, can improve memory and potentially treat Alzheimer's disease symptoms by removing damaged mitochondria from the brain. While the research has shown promising results in mouse models, human clinical trials are planned to determine the effective dosage and potential preventive benefits.
Researchers have found that urolithin A, a substance in pomegranates, strawberries, and walnuts, can help the brain remove damaged cells in mice with Alzheimer's disease. This process, known as mitophagy, helps clear out cellular debris that contributes to neurodegenerative diseases. While promising, further studies are needed to confirm its effects on humans and determine the appropriate dosage.
A study from the University of Copenhagen reveals that urolithin A, a compound found in pomegranates, can improve memory and potentially treat Alzheimer's disease by removing damaged mitochondria from the brain. Researchers are working to determine the optimal dosage for this promising natural treatment.